Post by
GoldsteinJ on Jan 10, 2018 6:42pm
Likelihood of ACB-CMED merger
From the Aurora circular, they need a minimum of 66.66% of shares tendered for the bid to pass.
What we know:
1. 38% have already been tendered from three major shareholders
2. Aurora will purchase up to 5% in the open-market
That leaves us with around 24% of common shares that CMED shareholders must tender. This seems like a big feat (if you disagree, I'd appreciate your input).
Comment by
mekelletigray on Jan 10, 2018 7:33pm
Where is the 66.66% coming from? In light me please. Why not 51%?
Comment by
Raguu17 on Jan 10, 2018 9:57pm
2 separate votes as far as I understand it. 1 from ACB holders approving our board. 66% 2nd from CMED approving the offer. 36% + recent purchases and committed holders
Comment by
cnixon15 on Jan 11, 2018 11:29am
Quarterly Sales Canopy Growth $13.9m (usd) MedReleaf $7.8m (usd) Aurora Cannabis $6.5m (usd) CannTrust $4.89m (usd) Aphria $4.87m (usd) Isodiol International $4m (usd) MPX Bioceutical $3.5m (usd) CanniMed Therapeutics $3.8m (usd) Namaste Technologies $2.5m (usd) Where is CanniMed on this list? And this is a 30-40$ stock. get real.
Comment by
Dowtown on Jan 11, 2018 12:01pm
According to Zettl It's a $50 stock but all that damn monopoly money from Aurora is holding him back. I'm not a lawyer but I feel it is illegal to just spew out speculative numbers when you are a aren't even licensed to give financial advice.
Comment by
6698Valley on Jan 11, 2018 12:13pm
Zettl feels sorry he did not take Aurora offer right off the bat, because it would get him around 50 bucks now.
Comment by
thorgb1 on Jan 11, 2018 2:29pm
You know, if you are going to invest in the ,Arlen, you really need to gain an understanding of market cap......